[Long-term efficacy and safety profile of pegaptanib sodium for age-related macular degeneration with choroidal neovascularization--evaluation of extended phase II clinical trial].  [electronic resource] 

 -  Nippon Ganka Gakkai zasshi  Feb 2011 
 - 122-33 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0029-0203 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Aptamers, Nucleotide--adverse effects<br/>Choroidal Neovascularization--complications<br/>Female<br/>Humans<br/>Macular Degeneration--drug therapy<br/>Male<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Visual Acuity